CompletedNCT06206291
Cannabidiol study for people receiving opioid treatment
About this title
Read the official source — NCT06206291Medication studyAges 18–65United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: October 4, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 76
- Sponsor
- Yasmin Hurd
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06206291
- Official title
Show the full official title
Cannabidiol in the Treatment of Opioid Use Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New York
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Yasmin Hurd.
Did this study involve medication?
Yes. The study involved medication, including Placebo, Cannabidiol (CBD) 200mg and Cannabidiol (CBD) 400mg.
Who was this study for?
Listed age limits: 18 years to 65 years.
